Prnewswireยท2025-10-29 13:00Core Insights - 10x Genomics has launched a next-generation high-performance Flex assay that features automation-compatible plate-based multiplexing, enabling cost-effective and scalable single-cell analysis for a variety of research applications [1][2][3] Group 1: Product Features - The new Flex assay allows researchers to profile up to 384 samples and 100 million cells per week using a 96-well plate format, integrating seamlessly with automated cell partitioning for reliable results [2] - Built on proven Flex chemistry, the assay offers exceptional sensitivity and sequencing efficiency, supporting modular usage and reducing reagent waste, thus delivering more data at a lower cost [2][3] - The assay enables the profiling of millions of cells at a fraction of the cost compared to traditional methods, significantly enhancing the ability to explore functional immune responses [4] Group 2: Market Impact - The advancements in scalability and ease of use are expected to unlock more research opportunities, allowing for more samples, conditions, and insights at reduced costs [3] - The new Flex assay is positioned as a transformative tool for large-scale foundational and translational studies, as well as routine single-cell applications [3] - Early access customers have already begun utilizing the new Flex assay across various discovery and translational research programs, indicating strong market interest [3][4] Group 3: Company Overview - 10x Genomics is a life science technology company focused on products that accelerate biological research and advance human health, with solutions that include instruments, consumables, and software for single-cell and spatial biology [5] - The company's products have contributed to breakthroughs in various fields, including oncology, immunology, and neuroscience, enhancing the understanding of health and disease [5]